Peripheral loss of EphA4 ameliorates TBI-induced neuroinflammation and tissue damage
dc.contributor.author | Kowalski, Elizabeth A. | en |
dc.contributor.author | Chen, Jiang | en |
dc.contributor.author | Hazy, Amanda | en |
dc.contributor.author | Fritsch, Lauren E. | en |
dc.contributor.author | Gudenschwager-Basso, Erwin K. | en |
dc.contributor.author | Chen, Michael | en |
dc.contributor.author | Wang, Xia | en |
dc.contributor.author | Qian, Yun | en |
dc.contributor.author | Zhou, Mingjun | en |
dc.contributor.author | Byerly, Matthew | en |
dc.contributor.author | Pickrell, Alicia M. | en |
dc.contributor.author | Matson, John B. | en |
dc.contributor.author | Allen, Irving C. | en |
dc.contributor.author | Theus, Michelle H. | en |
dc.contributor.department | Mechanical Engineering | en |
dc.contributor.department | Biomedical Sciences and Pathobiology | en |
dc.contributor.department | Chemistry | en |
dc.contributor.department | School of Neuroscience | en |
dc.contributor.department | Center for Drug Discovery | en |
dc.date.accessioned | 2019-11-18T13:02:47Z | en |
dc.date.available | 2019-11-18T13:02:47Z | en |
dc.date.issued | 2019-11-11 | en |
dc.date.updated | 2019-11-17T04:20:07Z | en |
dc.description.abstract | Background The continuum of pro- and anti-inflammatory response elicited by traumatic brain injury (TBI) is suggested to play a key role in the outcome of TBI; however, the underlying mechanisms remain ill -defined. Methods Here, we demonstrate that using bone marrow chimeric mice and systemic inhibition of EphA4 receptor shifts the pro-inflammatory milieu to pro-resolving following acute TBI. Results EphA4 expression is increased in the injured cortex as early as 2 h post-TBI and on CX3CR1gfp-positive cells in the peri-lesion. Systemic inhibition or genetic deletion of EphA4 significantly reduced cortical lesion volume and shifted the inflammatory profile of peripheral-derived immune cells to pro-resolving in the damaged cortex. These findings were consistent with in vitro studies showing EphA4 inhibition or deletion altered the inflammatory state of LPS-stimulated monocyte/macrophages towards anti-inflammatory. Phosphoarray analysis revealed that EphA4 may regulate pro-inflammatory gene expression by suppressing the mTOR, Akt, and NF-κB pathways. Our human metadata analysis further demonstrates increased EPHA4 and pro-inflammatory gene expression, which correlates with reduced AKT concurrent with increased brain injury severity in patients. Conclusions Overall, these findings implicate EphA4 as a novel mediator of cortical tissue damage and neuroinflammation following TBI. | en |
dc.description.version | Published version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Journal of Neuroinflammation. 2019 Nov 11;16(1):210 | en |
dc.identifier.doi | https://doi.org/10.1186/s12974-019-1605-2 | en |
dc.identifier.uri | http://hdl.handle.net/10919/95564 | en |
dc.language.iso | en | en |
dc.rights | Creative Commons Attribution 4.0 International | en |
dc.rights.holder | The Author(s) | en |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en |
dc.title | Peripheral loss of EphA4 ameliorates TBI-induced neuroinflammation and tissue damage | en |
dc.title.serial | Journal of Neuroinflammation | en |
dc.type | Article - Refereed | en |
dc.type.dcmitype | Text | en |